Cargando…

Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis

BACKGROUND: Dual antiplatelet therapy is usually superior to mono therapy in preventing recurrent vascular events (VEs). This systematic review assesses the safety and efficacy of triple antiplatelet therapy in comparison with dual therapy in reducing recurrent vascular events. METHODS: Completed ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geeganage, Chamila, Wilcox, Robert, Bath, Philip MW
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Research article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893089/ https://www.ncbi.nlm.nih.gov/pubmed/20553581 http://dx.doi.org/10.1186/1741-7015-8-36

Ejemplares similares

Association between hormone replacement therapy and subsequent arterial and venous vascular events: a meta-analysis
por: Sare, Gillian M., et al.
Publicado: (2008)

A Randomised Controlled Trial of Triple Antiplatelet Therapy (Aspirin, Clopidogrel and Dipyridamole) in the Secondary Prevention of Stroke: Safety, Tolerability and Feasibility
por: Sprigg, Nikola, et al.
Publicado: (2008)

Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke’ (TARDIS) trial
por: Bath, Philip M W, et al.
Publicado: (2015)

Determining the Feasibility of Ambulance-Based Randomised Controlled Trials in Patients with Ultra-Acute Stroke: Study Protocol for the “Rapid Intervention with GTN in Hypertensive Stroke Trial” (RIGHT, ISRCTN66434824)
por: Ankolekar, Sandeep, et al.
Publicado: (2012)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Antiplatelets and Vascular Dementia: A Systematic Review
por: Alexander, Peter, et al.
Publicado: (2022)

Oral Antiplatelet Therapy for Secondary Prevention of Non-Cardioembolic Ischemic Cerebrovascular Events
por: De Luca, Leonardo, et al.
Publicado: (2021)

Dual antiplatelet therapy with concomitant anticoagulation: current perspectives on triple therapy
por: Patail, Haris, et al.
Publicado: (2023)

Antiplatelet Therapy After Noncardioembolic Stroke: An Individual Patient Data Network Meta-Analysis
por: Greving, Jacoba P., et al.
Publicado: (2019)

Perioperative Management of Antiplatelet Therapy: A Systematic Review and Meta-analysis
por: Shah, Sahrish, et al.
Publicado: (2022)

Antiplatelet/anticoagulant agents for preventing thrombosis events in patients with severe COVID-19: A protocol for systematic review and meta-analysis
por: Li, Yiwei, et al.
Publicado: (2020)

Dual Antiplatelet Therapy vs. Single Antiplatelet Therapy After Transcatheter Aortic Valve Replacement: An Updated Systematic Review and Meta-Analysis
por: Zhang, Yipeng, et al.
Publicado: (2021)

Comparing the effectiveness and safety between triple antiplatelet therapy and dual antiplatelet therapy in type 2 diabetes mellitus patients after coronary stents implantation: a systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2015)

Triple Therapy Versus Dual Antiplatelet Therapy for Patients with  Atrial Fibrillation and Acute Coronary Syndromes: A Systematic  Literature Review
por: Fake, Aimee, et al.
Publicado: (2017)

Does prior use of antiplatelet therapy modify the effect of dual antiplatelet therapy in transient ischaemic attack/minor ischaemic stroke: A systematic review and meta‐analysis
por: Clarke, Aoibhin, et al.
Publicado: (2022)

The use of dual antiplatelet therapy for ischemic cerebrovascular events
por: Mele, Francesco, et al.
Publicado: (2022)

Precision antiplatelet therapy for the prevention of ischaemic stroke
por: Wang, David
Publicado: (2021)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018)

Antiplatelet therapy in patients undergoing oral surgery: A systematic review and meta-analysis
por: Villanueva, Julio, et al.
Publicado: (2019)

Benefits and risks of antiplatelet therapy for moyamoya disease: a systematic review and meta-analysis
por: Liu, Tingting, et al.
Publicado: (2023)

Oral anticoagulation versus antiplatelet therapy for secondary stroke prevention in patients with embolic stroke of undetermined source: A systematic review and meta-analysis
por: Hariharan, Nikhil Nair, et al.
Publicado: (2022)

Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials
por: Woodhouse, Lisa J., et al.
Publicado: (2021)

The preventive effect of antiplatelet therapy in acute respiratory distress syndrome: a meta-analysis
por: Wang, Yingqin, et al.
Publicado: (2018)

Bleeding with intensive versus guideline antiplatelet therapy in acute cerebral ischaemia
por: Woodhouse, Lisa J., et al.
Publicado: (2023)

Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis
por: Liu, Liyao, et al.
Publicado: (2018)

The clinical outcomes of triple antiplatelet therapy versus dual antiplatelet therapy for high-risk patients after coronary stent implantation: a meta-analysis of 11 clinical trials and 9,553 patients
por: Fan, Zhong-Guo, et al.
Publicado: (2016)

An up-dated meta-analysis of major adverse cardiac events on triple versus dual antiplatelet therapy after percutaneous coronary intervention in patients with type 2 diabetes mellitus
por: Liu, Mao, et al.
Publicado: (2018)

Optimization of antiplatelet/antithrombotic therapy for secondary stroke prevention
por: Srivastava, Padma
Publicado: (2010)

Antiplatelet therapy in secondary stroke prevention – state of the art
por: Diener, Hans-Christoph, et al.
Publicado: (2010)

Prognostic impact of antiplatelet therapy in Takotsubo syndrome: a systematic review and meta-analysis of the literature
por: Rizzetto, Francesca, et al.
Publicado: (2021)

Efficacy and safety outcomes of oral anticoagulants and antiplatelet drugs in the secondary prevention of venous thromboembolism: systematic review and network meta-analysis
por: Castellucci, Lana A, et al.
Publicado: (2013)

Comparison of Systematic Ticagrelor-Based Dual Antiplatelet Therapy to Selective Triple Antithrombotic Therapy for Left Ventricle Dysfunction Following Anterior STEMI
por: Bastiany, Alexandra, et al.
Publicado: (2018)

Triple versus dual antiplatelet therapy for coronary heart disease patients undergoing percutaneous coronary intervention: A meta-analysis
por: ZHOU, HONG, et al.
Publicado: (2013)

Case‐fatality rate of major bleeding events in patients on dual antiplatelet therapy after percutaneous coronary intervention: A systematic review and meta‐analysis
por: Tritschler, Tobias, et al.
Publicado: (2022)

Antiplatelet therapy and incident cognitive impairment or dementia—a systematic review and meta-analysis of randomised clinical trials
por: Kitt, Kevin, et al.
Publicado: (2023)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

Dental management in patients with antiplatelet therapy: A systematic review
por: Sáez-Alcaide, Luis-Miguel, et al.
Publicado: (2017)

The role of CYP2C19 genotyping to guide antiplatelet therapy following ischemic stroke or transient ischemic attack
por: McDermott, John H, et al.
Publicado: (2022)

Comparison between single antiplatelet therapy and combination of antiplatelet and anticoagulation therapy for secondary prevention in ischemic stroke patients with antiphospholipid syndrome
por: Okuma, Hirohisa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_pkjsh2vpm59p582ppscl3ieril